Risk of Severe COVID–19 Outcomes Among Patients with Rheumatoid Arthritis in the United States

Ching-Yi Chuo, Vince Yau, Sriraman Madhavan, Larry Tsai, Jenny Chia
doi: https://doi.org/10.1101/2021.07.09.21260106

Article Information

doi 
https://doi.org/10.1101/2021.07.09.21260106
History 
  • July 12, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Ching-Yi Chuo1,
  2. Vince Yau1,*,
  3. Sriraman Madhavan1,
  4. Larry Tsai2 and
  5. Jenny Chia1
  1. 1Personalized Health Care, Genentech, South San Francisco, United States
  2. 2Product Development, Genentech, South San Francisco, United States
  1. ↵*Corresponding Author Vincent Yau
    , Postal Address Genentech, Building 40, 600 E Grand Ave, South San Francisco, 94080, Email yau.vincent{at}gene.com

  1. Contributorship: All authors in this manuscript contributed in a meaningful and significant manner.

Back to top
Posted July 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Risk of Severe COVID–19 Outcomes Among Patients with Rheumatoid Arthritis in the United States
Ching-Yi Chuo, Vince Yau, Sriraman Madhavan, Larry Tsai, Jenny Chia
medRxiv 2021.07.09.21260106; doi: https://doi.org/10.1101/2021.07.09.21260106
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area